AbbVie Earnings Preview
Portfolio Pulse from Benzinga Insights
AbbVie (NYSE:ABBV) is scheduled to release its quarterly earnings report on February 2, 2024, with analysts expecting an EPS of $2.58. The company's past performance shows a mix of earnings beats and misses, with varying impacts on its stock price. Shares have risen 13.52% over the last year, indicating a positive outlook among long-term investors. The upcoming earnings report and particularly the company's guidance for future quarters will be key factors influencing the stock's short-term performance.
February 01, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AbbVie is expected to report an EPS of $2.58 for the upcoming quarter. Historical data shows its stock price can fluctuate post-earnings, but long-term trends have been positive with a 13.52% increase over the past year.
Given AbbVie's history of beating EPS estimates and the positive long-term stock performance, the upcoming earnings report is likely to have a positive impact, especially if the company provides strong future guidance. However, the stock's reaction to past earnings and the importance of guidance suggest that investor reactions can be mixed.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100